GB9820767D0 - Chemical compounds VIII - Google Patents

Chemical compounds VIII

Info

Publication number
GB9820767D0
GB9820767D0 GBGB9820767.3A GB9820767A GB9820767D0 GB 9820767 D0 GB9820767 D0 GB 9820767D0 GB 9820767 A GB9820767 A GB 9820767A GB 9820767 D0 GB9820767 D0 GB 9820767D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds viii
viii
chemical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9820767.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis Research Ltd
Original Assignee
Cerebrus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerebrus Ltd filed Critical Cerebrus Ltd
Priority to GBGB9820767.3A priority Critical patent/GB9820767D0/en
Publication of GB9820767D0 publication Critical patent/GB9820767D0/en
Priority to AU61045/99A priority patent/AU6104599A/en
Priority to PCT/GB1999/003187 priority patent/WO2000017170A2/en
Ceased legal-status Critical Current

Links

GBGB9820767.3A 1998-09-23 1998-09-23 Chemical compounds VIII Ceased GB9820767D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9820767.3A GB9820767D0 (en) 1998-09-23 1998-09-23 Chemical compounds VIII
AU61045/99A AU6104599A (en) 1998-09-23 1999-09-23 Chemical compounds viii
PCT/GB1999/003187 WO2000017170A2 (en) 1998-09-23 1999-09-23 N1-substituted benzopyrazoles as inhibitors of 5-ht2 receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9820767.3A GB9820767D0 (en) 1998-09-23 1998-09-23 Chemical compounds VIII

Publications (1)

Publication Number Publication Date
GB9820767D0 true GB9820767D0 (en) 1998-11-18

Family

ID=10839365

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9820767.3A Ceased GB9820767D0 (en) 1998-09-23 1998-09-23 Chemical compounds VIII

Country Status (3)

Country Link
AU (1) AU6104599A (en)
GB (1) GB9820767D0 (en)
WO (1) WO2000017170A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030065304A (en) * 2000-03-17 2003-08-06 알콘, 인코퍼레이티드 6-Hydroxy-indazole derivatives for treating glaucoma
US6956036B1 (en) 2000-03-17 2005-10-18 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
CA2449899C (en) 2000-11-20 2010-04-06 Biovitrum Ab Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
SE0004245D0 (en) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
CA2485537A1 (en) 2002-06-19 2003-12-31 Biovitrum Ab Novel compounds, their use and preparation
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
JP4617299B2 (en) * 2003-03-03 2011-01-19 アレイ バイオファーマ、インコーポレイテッド p38 inhibitors and methods of use thereof
CL2004000826A1 (en) 2003-04-25 2005-03-04 Pfizer USE OF AN AGONIST FOR THE 5-HT2C RECEPTOR TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF URINARY INCONTINENCE CAUSED BY STRESS, WITH THE CONDITION THAT THE AGONIST IS NOT 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2- PIRIDINIL] PIPERAZINA (ORG-129
GB0314967D0 (en) 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
EP2400300A1 (en) 2004-08-25 2011-12-28 Takeda Pharmaceutical Company Limited Method of screening preventives/remedies for stress urinary incontinence
JP5131990B2 (en) 2006-01-31 2013-01-30 アレイ バイオファーマ、インコーポレイテッド Kinase inhibitors and methods of use thereof
WO2007132841A1 (en) 2006-05-16 2007-11-22 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
EP2216023A4 (en) 2007-11-15 2013-03-13 Takeda Pharmaceutical Condensed pyridine derivative and use thereof
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited Therapeutic agent for stress urinary incontinence and fecal incontinence

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403738B (en) * 1994-08-12 2000-09-01 Hoffmann La Roche Tricyclic pyrazole derivatives
JP3560986B2 (en) * 1997-01-13 2004-09-02 山之内製薬株式会社 5-HT2C receptor agonist and aminoalkylindazole derivative
GB9819032D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds IV

Also Published As

Publication number Publication date
AU6104599A (en) 2000-04-10
WO2000017170A3 (en) 2000-08-03
WO2000017170A2 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
GB9800428D0 (en) Chemical compounds
GB9813565D0 (en) Chemical compounds
GB9811159D0 (en) Chemical compounds
GB9812709D0 (en) Chemical compounds
GB9812088D0 (en) Chemical compounds
GB9804343D0 (en) Chemical compounds
GB9820767D0 (en) Chemical compounds VIII
GB9804861D0 (en) Chemical compounds
GB9815785D0 (en) Chemical compounds
GB9801812D0 (en) Chemical compounds
GB9802028D0 (en) Chemical compounds
GB9809161D0 (en) Chemical compounds
GB9816116D0 (en) Chemical compounds
GB9815970D0 (en) Chemical compounds
GB9808431D0 (en) Chemical compounds
GB9811157D0 (en) Chemical compounds
GB9801963D0 (en) Chemical compounds
GB9800396D0 (en) Chemical compounds
GB0031382D0 (en) Chemical compounds
GB9807579D0 (en) Chemical compounds
GB9822617D0 (en) Chemical compounds
GB9816193D0 (en) Chemical compounds
GB9811417D0 (en) Chemical compounds
GB9816192D0 (en) Chemical compounds
GB9807578D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)